Vik Chopra Stock Analyst Profile - Wells Fargo Research Coverage - Stocknear

Vik Chopra

Stock Analyst at Wells Fargo

(3.28)
# 2836
Out of 5,506 analysts
52
Total ratings
Success rate
Average return

13 Stocks

Name Action PT Current % Upside Ratings Updated
SOLV Solventum
Maintains: Equal-Weight
79 82
74 10.81% 5 Sep 15, 2025
NPCE NeuroPace
Maintains: Overweight
17 15
10.93 37.24% 3 Aug 13, 2025
GMED Globus Medical
Maintains: Overweight
76 66
60.5 9.09% 10 Aug 8, 2025
ENOV Enovis
Maintains: Overweight
48 41
31.96 28.29% 4 Aug 8, 2025
XRAY Dentsply Sirona
Maintains: Equal-Weight
16 15
13.19 13.72% 3 Aug 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
17 19
20.83 -8.79% 3 Aug 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
246 199
132.25 50.47% 3 Jul 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
205 190
147.32 28.97% 9 May 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
25 13
14.82 -12.28% 2 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
80 75
67.07 11.82% 2 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
70 57
48.03 18.68% 5 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
26 19
13.96 36.1% 1 Aug 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
47 58
n/a n/a 2 Feb 10, 2023